Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres

Documenti analoghi

• Single‐centre experience with tralokinumab in dupilumab‐experienced and naïve patients with atopic dermatitis
  di: Claire Fossati, et al.
  Pubblicazione: (2024)
• Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real‐world comparative study
  di: Tiago Torres, et al.
  Pubblicazione: (2025)
• Paediatric cutaneous lymphomas including rare subtypes: A 40‐year experience at a tertiary referral centre
  di: Silvia Alberti‐Violetti, et al.
  Pubblicazione: (2024)
• Clearance of Darier disease lesions in a patient with concomitant atopic dermatitis treated with abrocitinib
  di: M. Bianco, et al.
  Pubblicazione: (2024)
• Five‐year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real‐world study
  di: Luigi Gargiulo, et al.
  Pubblicazione: (2025)